CDHA CAAR

August 2, 2013

CAAR – Lancet Article Abstract – August 2, 2013

Filed under: Reports and Articles — Tags: , — admin @ 4:14 pm

Note: Lancet requires free registration prior to providing content. “Individualised treatment targets for elderly patients with type 2 diabetes using vildagliptin add-on or lone therapy (INTERVAL): a 24 week, randomised, double-blind, placebo-controlled study,” by W. David Strain, Valentina Lukashevich, Wolfgang Kothny, Marie-Jose Hoellinger, and Paivi Maria Paldanius (Vol. 382, No. 9890, August 3, 2013, p. 407-416).

www.thelancet.com/journals/lancet/article/PIIS0140-6736(13)60995-2/abstract

No Comments

No comments yet.

RSS feed for comments on this post.

Sorry, the comment form is closed at this time.

Powered by WordPress